A rare case report about a congenital adrenal hyperplasia by 21-hydroxylase lock in its pure virilizing form discovered in adolescence.
17OHP, 17 hydroxyprogesterone
21-Hydroxylase deficiency
ACTH, Adrenocorticotropic Hormone
CAH, Congenital adrenal hyperplasia
CMIA, Chemiluminescence microparticle immunology
CPA, Cyproterone Acetate
CYP21, the gene encoding 21-hydroxylase, a cytochrome P-450 enzyme
Case report
Congenital adrenal hyperplasia
PCR, Polymerase Chain Reaction
Pure virilizing form
SDHEA, Dehydroepiandrosterone Sulfate
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
23
02
2022
revised:
21
04
2022
accepted:
25
04
2022
entrez:
20
5
2022
pubmed:
21
5
2022
medline:
21
5
2022
Statut:
epublish
Résumé
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is an autosomal recessive disease. The diagnosis of the classic virilizing form must be made at birth. We report the case of a 16-year-old female patient, who consulted for primary amenorrhea and absence of breast development, in whom the clinical examination found a male morphotype, signs of virilization with a peniform hypertrophy of the clitoris. Pelvic ultrasound confirmed the presence of the uterus and ovaries. A syacthen test on 17 hydroxy-progesterone was performed confirming the diagnosis of congenital adrenal hyperplasia by partial 21-hydroxylase deficiency. The treatment was based on hydrocortisone and spironolactone with a decrease in hairiness and a breast development after 3 months. The principal aim of the management at adolescent age is to block hyperandrogenism and to prevent or manage the complications of classic form and its treatment. The treatment must be completed by a feminization surgery which constitutes a great challenge given the necessity of participation of a gynecologist and a pediatric surgeon experienced in the surgery of anomalies of sexual development. This rare case of anomaly of sexual development discovered at an adolescent age with all the obstacles and difficulties of its management allows to put the point on the necessity of a good clinical examination at birth and the early management of any anomaly of sexual development.
Identifiants
pubmed: 35592826
doi: 10.1016/j.amsu.2022.103673
pii: S2049-0801(22)00433-2
pmc: PMC9111920
doi:
Types de publication
Case Reports
Langues
eng
Pagination
103673Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Mol Diagn Ther. 2018 Jun;22(3):261-280
pubmed: 29450859
N Engl J Med. 2003 Aug 21;349(8):776-88
pubmed: 12930931
Lancet. 2017 Nov 11;390(10108):2194-2210
pubmed: 28576284
Genet Med. 2017 Nov;19(11):1276-1279
pubmed: 28541281
J Clin Endocrinol Metab. 2006 Sep;91(9):3451-6
pubmed: 16822826
Rev Endocr Metab Disord. 2007 Dec;8(4):349-63
pubmed: 17885806
J Clin Endocrinol Metab. 1990 Mar;70(3):642-6
pubmed: 2137832
Pediatrics. 1998 Apr;101(4 Pt 1):583-90
pubmed: 9521938
J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):957-966
pubmed: 28787274
J Diet Suppl. 2013 Dec;10(4):381-90
pubmed: 24237192
J Endocr Soc. 2019 Apr 11;3(6):1150-1153
pubmed: 31139761
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4043-4088
pubmed: 30272171
Presse Med. 2014 Apr;43(4 Pt 1):428-37
pubmed: 24630263
Gynecol Obstet Fertil. 2014 Jun;42(6):422-8
pubmed: 24852906